$60.00 $2.00 per serving
Product analysis
ResveraCel combines resveratrol with other ingredients linked to normal cellular processes, but practical benefits remain uncertain. Its relatively high cost makes that uncertainty relevant when comparing alternatives.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality26
Incomplete form details limit a confident quality comparison. The quercetin preparation is named, but that alone does not establish an absorption advantage.
Ingredient Transparency58
All listed amounts are stated, but most form details are incomplete. The quercetin complex also lacks a complete breakdown, making direct preparation comparisons difficult.
Value For Money26
Value is less favorable for the vitamin B3-related ingredient and resveratrol. Betaine has a more favorable serving comparison, while quercetin’s value remains uncertain.
Customer Satisfaction86
Customer feedback is strongly positive across a large review pool. The volume offers a broad picture of satisfaction, without proving health effects.
Product Focus58
The formula targets several aspects of cellular, skin and heart-related health. Those biochemical links provide limited support for broad practical benefits or slower aging.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $2.00
- Customer rating
- 4.6 · 4,429 ratings
Goals
Impact
Moderate effect
Trans-resveratrol at 150 mg may influence inflammatory signaling, but the supplied evidence shows limited and inconsistent changes in inflammatory markers. Quercetin is also present at 250 mg; the supplied broader trial was mostly null, so it adds little support for this goal.
How this product is rated for Inflammation
Ingredient fit71
Resveratrol provides the main supported contribution within a broader combination. The 150 mg trans-resveratrol amount matches the supplied study exposure.
Goal fit
Resveratrol provides the main supported contribution within a broader combination.
Dose adequacy
The 150 mg trans-resveratrol amount matches the supplied study exposure.
Pathways19
The relevant contribution centers on inflammatory gene signaling. The overall range of support remains limited.
Depth
The relevant contribution centers on inflammatory gene signaling.
Breadth
No route reaches the saved threshold for broad pathway coverage.
Evidence62
Resveratrol has limited, inconsistent biomarker evidence rather than an established broad clinical benefit. The declared trans-resveratrol matches the preparation accepted in the saved findings.
Evidence strength
Resveratrol has limited, inconsistent biomarker evidence rather than an established broad clinical benefit.
Studied preparation
The declared trans-resveratrol matches the preparation accepted in the saved findings.
Formulation logic100
Resveratrol can contribute without a required additional partner. No ingredient conflicts were identified in the saved assessment.
Partner coverage
The relevant ingredients can contribute without a required additional partner.
Conflicts
No ingredient conflicts were identified in the saved assessment.
Effective doses
Resveratrol meets the saved minimum for a meaningful dose contribution.
Impact
Moderate effect
Resveratrol at 150 mg has a bounded connection to cognitive performance and brain blood-flow function: the supplied evidence includes a positive trial in postmenopausal women alongside a trial that missed its memory endpoint.
The niacin-group declaration includes nicotinamide riboside hydrogen malate, whose compound mass is not the same as active NR. Quercetin and betaine add biochemical rationales, but these ingredients do not establish broadly preserved function or slower aging.
How this product is rated for Longevity
Ingredient fit78
The relevant ingredients sit within a broader mix aimed at several needs. The assessed amounts fully meet the saved comparison benchmarks.
Goal fit
The relevant ingredients sit within a broader mix aimed at several needs.
Dose adequacy
The assessed amounts fully meet the saved comparison benchmarks.
Pathways60
The strongest assessed area is cerebrovascular function, with substantial coverage. One assessed area reaches the threshold for substantial coverage.
Depth
The strongest assessed area is cerebrovascular function, with substantial coverage.
Breadth
One assessed area reaches the threshold for substantial coverage.
Evidence52
Resveratrol provides the strongest evidence contribution among the assessed ingredients, with important limits on broader healthy-aging claims. The assessed ingredients meeting the amount threshold match the preparations recognized in the saved findings.
Evidence strength
Resveratrol provides the strongest evidence contribution among the assessed ingredients, with important limits on broader healthy-aging claims.
Studied preparation
The assessed ingredients meeting the amount threshold match the preparations recognized in the saved findings.
Formulation logic100
The assessed ingredients can contribute independently or have their required partner. No configured ingredient conflict was matched in the supplied assessment. All ingredients included in this check reach its minimum amount threshold.
Partner coverage
The assessed ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was matched in the supplied assessment.
Effective doses
All ingredients included in this check reach its minimum amount threshold.
Impact
Moderate effect
Niacin · 415 mgResveratrol · 150 mg
Whether nicotinamide riboside increases your body's calorie burning is unclear. Its declared compound mass can't automatically be treated as an equivalent amount of free nicotinamide riboside. Resveratrol's connection with metabolic processes also doesn't by itself imply a faster metabolic rate.
How this product is rated for Metabolism Support
Ingredient fit54
The declared ingredients have roles in metabolism, but normal nutrient functions and a direct increase in calorie burning are different outcomes.
Goal fit
Nicotinamide riboside, Resveratrol are present; their metabolic roles don't necessarily imply increased calorie burning.
Dose adequacy
Nicotinamide riboside 415 mg, Resveratrol 150 mg per label serving; these amounts alone don't prove a metabolic-rate increase.
Pathways46
Resveratrol relates to cellular energy processes; that connection doesn't prove a rise in whole-body calorie burning.
Depth
Resveratrol relates to cellular energy processes; that connection doesn't prove a rise in whole-body calorie burning.
Breadth
The connection is concentrated in cellular energy processes; additional distinct routes to increased calorie burning aren't demonstrated.
Evidence81
Whether nicotinamide riboside increases your body's calorie burning is unclear. Its declared compound mass can't automatically be treated as an equivalent amount of free nicotinamide riboside.
Evidence strength
Resveratrol has a relevant metabolic role, but this doesn't imply that extra intake reliably raises energy expenditure.
Studied preparation
The ingredient preparations match the applicable preparation descriptions; that match alone doesn't guarantee a rise in calorie burning.
Formulation logic100
No particular ingredient conflict is identified. Ingredient amounts and preparation details still determine what can be expected from the combination.
Partner coverage
No required ingredient partner is missing for the applicable ingredients; this doesn't imply an added benefit from combining them.
Conflicts
No particular ingredient conflict is identified.
Effective doses
The applicable ingredients have amounts within their dose comparison ranges; these ranges don't define a minimum effective dose.
Impact
Moderate effect
Quercetin at 250 mg relates to blood-vessel function, but the supplied blood-pressure findings were clearer at 500 mg per day or more. Resveratrol at 150 mg has uncertain routine heart benefits, and the supplied trial at that amount did not improve cardiovascular risk markers. The nicotinamide-riboside source is not an established niacin dose for heart support.
How this product is rated for Heart Health
Ingredient fit56
The heart-relevant ingredients share the formula with ingredients directed at other uses. The declared amounts provide partial coverage of the amounts used in the saved assessment.
Goal fit
The heart-relevant ingredients share the formula with ingredients directed at other uses.
Dose adequacy
The declared amounts provide partial coverage of the amounts used in the saved assessment.
Pathways10
The strongest saved contribution concerns blood-vessel lining function, with partial coverage. No selected pathway reaches the saved threshold for substantial coverage.
Depth
The strongest saved contribution concerns blood-vessel lining function, with partial coverage.
Breadth
No selected pathway reaches the saved threshold for substantial coverage.
Evidence58
Resveratrol provides the strongest saved evidence among ingredients at an assessed effective amount; the findings do not imply prevention of heart events. The saved findings recognize the assessed effective ingredients as studied preparations.
Evidence strength
Resveratrol provides the strongest saved evidence among ingredients at an assessed effective amount; the findings do not imply prevention of heart events.
Studied preparation
The saved findings recognize the assessed effective ingredients as studied preparations.
Formulation logic92
The credited ingredients can contribute independently or have their required partners. No configured ingredient conflicts were recorded in the saved findings. Two of the three credited ingredients meet the saved minimum; the unresolved niacin amount falls below it.
Partner coverage
The credited ingredients can contribute independently or have their required partners.
Conflicts
No configured ingredient conflicts were recorded in the saved findings.
Effective doses
Two of the three credited ingredients meet the saved minimum; the unresolved niacin amount falls below it.
Impact
Moderate effect
Niacin · 415 mg
ResveraCel declares 150 mg resveratrol and 250 mg quercetin per serving, with endothelial nitric-oxide function as its clearest pathway link. Neither amount yields broad coverage, and the nicotinic-acid amount is unresolved; betaine has no reviewed role in this goal. These marker links do not establish heart-attack or stroke prevention.
How this product is rated for Cardiovascular Support
Ingredient fit55
Resveratrol and quercetin are goal-linked; the nicotinic-acid amount is unknown, and betaine has no reviewed cardiovascular role.
Goal fit
Resveratrol and quercetin drive the goal link; betaine is off-goal and the niacin amount remains unresolved.
Dose adequacy
The declared resveratrol and quercetin amounts contribute; unresolved niacin adds no dose support.
Pathways10
Endothelial nitric-oxide function leads, but no target pathway reaches the broader coverage mark.
Depth
Endothelial nitric-oxide function has the clearest, though limited, coverage.
Breadth
None of the three target pathways reaches the coverage mark.
Evidence55
Resveratrol has the clearest supplied evidence link, with quercetin also represented in studied preparations.
Evidence strength
Resveratrol carries the strongest evidence link among the goal-related ingredients, though its evidence ceiling is limited.
Studied preparation
Resveratrol and quercetin are represented in relevant studies at effective amounts.
Formulation logic92
The contributing ingredients have no missing partner or matched conflict; the unresolved niacin amount does not reach the minimum dose mark.
Partner coverage
Resveratrol and quercetin can contribute without a missing companion.
Conflicts
No listed conflict is matched to the declared ingredients.
Effective doses
Resveratrol and quercetin clear the minimum dose mark; niacin does not because its amount is unresolved.
Impact
Moderate effect
Resveratrol · 150 mg
Resveratrol at 150 mg is the main skin-related ingredient, with limited evidence relevant to antioxidant protection. Findings from a multi-ingredient blend cannot be attributed to resveratrol alone. The vitamin B3-related ingredient supports normal nutrient functions, but its usable vitamin B3 amount is unresolved.
How this product is rated for Skin Health
Ingredient fit55
The saved assessment identifies 2 skin-related ingredients alongside a broader product purpose. Only one of the two assessed ingredients has a usable amount.
Goal fit
The saved assessment identifies 2 skin-related ingredients alongside a broader product purpose.
Dose adequacy
Only one of the two assessed ingredients has a usable amount.
Pathways44
The saved findings place the strongest support in uv antioxidant defence.
Depth
The saved findings place the strongest support in uv antioxidant defence.
Breadth
One mechanism reached the saved coverage benchmark: uv antioxidant defence. Other skin mechanisms were less well covered.
Evidence83
Resveratrol provides the strongest evidence contribution in the saved assessment. Normal nutrient roles and findings in selected populations should not be read as guaranteed cosmetic improvement.
Evidence strength
Resveratrol provides the strongest evidence contribution in the saved assessment. Normal nutrient roles and findings in selected populations should not be read as guaranteed cosmetic improvement.
Studied preparation
The ingredients with usable amounts met the saved preparation criteria; that match alone does not establish visible skin improvement.
Formulation logic88
1 of 2 assessed ingredients meet the saved minimum amount benchmark. No ingredient conflicts were identified in the saved assessment.
Partner coverage
The assessed ingredients can contribute without an additional partner, or the required partner is present.
Conflicts
No ingredient conflicts were identified in the saved assessment.
Effective doses
1 of 2 assessed ingredients meet the saved minimum amount benchmark.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Nicotinamide Riboside Hydrogen Malate | 415 mg | |
Quercetin Phytosome (Phospholipid Complex, Sophora japonica Flower Extract) | 250 mg | |
Trans-Resveratrol | 150 mg | |
Betaine Anhydrous | 85 mg |
Betaine Anhydrous · 85 mg OverallScore95
The label lists 85 mg of betaine anhydrous per serving, so its amount is clear. A whole-product serving costs about $2.00, placing it in the middle price tier.
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
The ingredient is identified as betaine anhydrous.
Betaine Form (Anhydrous/TMG vs. HCl)
The label specifies the anhydrous form of betaine.
Dose, Safety & Label Transparency100
The disclosed amount is 85 mg of betaine anhydrous per serving.
Label Transparency & Blend Disclosure
The betaine anhydrous amount is listed as 85 mg per serving.
Value75
A whole-product serving costs about $2.00, placing it in the middle price tier.
Price per Active Dose Efficiency
The whole-product serving price is about $2.00, in the middle price tier.
Niacin · 415 mg OverallScore69
Resveratrol · 150 mg OverallScore73
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.
- Effects of niacin on apo A1 and B levels: a systematic review and meta-analysis of randomised controlled trials.
- Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials.
- Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
- Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.
- Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial.
- Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.
- Resveratrol Supplementation and its Potential Benefits in Obesity-related Non-communicable Diseases.
- Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults.
- Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind, placebo-controlled trial.
- Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I.
- The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration.
- The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome.
- Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.
- Effect of niacin on endothelial function: a systematic review and meta-analysis of randomized controlled trials.
- A Meta-Analysis of the Impact of Resveratrol Supplementation on Markers of Renal Function and Blood Pressure in Type 2 Diabetic Patients on Hypoglycemic Therapy.
- Resveratrol Improves Heart Function by Moderating Inflammatory Processes in Patients with Systolic Heart Failure.
- Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus.
- Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.
- Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial.